Flagship Pioneering, Metaphore Biotechnologies Strike Deal with Novo Nordisk to Develop High-End Obesity Treatments

Estimated read time 1 min read

The collaboration is a part of a broader strategy to combat cardiometabolic and rare diseases.

You May Also Like

More From Author

+ There are no comments

Add yours